web analytics
1.8 C
Munich
Sunday, December 4, 2022

Stock in Focus: PURE Bioscience (OTCMKTS:PURE)

PURE Bioscience (OTCMKTS:PURE) is moving steadily downward in recent trading towards previously established support levels of $0.50. PURE is an ex NASDAQ stock that only recently started trading on the bb’s and it has been highly volatile since. PURE was recently the subject of a CNN i-report which helped get the word out on this sleeper. According to the report by Vaccikne1: PURE Bioscience, Inc. (OTCQB: PURE) Has Joined Other Top Ebola Stock Movers

With the first recorded Ebola death reaching U.S. soil, citizens are becoming more concerned about this deadly disease. As always, investors have looked for stock opportunities to arise from increased media attention. Several companies have seen excellent price action stemming from their health sector involvement and potential Ebola treatment participation.

PURE’s hard surface disinfectant and food contact surface sanitizer product kills bacteria in just 30 seconds. This is a powerful disinfectant, which can be used to kill pathogens like MRSA, fungi, and even some viruses like HIV, Norovirus, Influenza A, Avian Influenza, and H1N1. Updates on the effects of the disinfectant on the Ebola virus have not yet been released. Investors are still waiting for this information. With the recent speculation in the bioscience industry, PURE has developed a great deal of attention from traders, seeing share prices surging as high as $1.20. Accumulation has surged on the speculation, and volume has reached record levels. Additionally, the company just released an update promising to reduce pathogens on leafy greens. The company has released exciting updates to shareholders, which is helping to catalyze this price action.

PURE Bioscience (OTCMKTS:PURE) is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena — providing solutions to the health and environmental challenges of pathogen and hygienic control.

PURE technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it.

To Find out the inside Scoop on PURE Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

On October 17 PURE announced that PURE Hard Surface disinfectant has been made available for use in the almost 27,000 SUBWAY(R) franchised locations in the U.S.

PURE Hard Surface disinfectant, which is powered by the patented, non-toxic, environmentally friendly SDC antimicrobial molecule, fits perfectly into SUBWAY(R)’s commitment to greener living and its food safety protocol. A leader in the quick service restaurant industry, all SUBWAY(R) restaurants are required to follow policies in support of SUBWAY(R)’s overall commitment to make its restaurants and operations as environmentally and socially responsible as possible. The availability of the powerful PURE Hard Surface disinfectant will strengthen the quick service restaurant chain’s sanitization program.

We have a Monster Pick Coming. Subscribe Right Now!

Conclusion: PURE is exploding upwards again recent surpassing the $0.80 mark after a recent bear raid took the stock to lows of $0.49. The stock has benefited greatly from the recent Ebola influx of interest but this Company has a lot more going on that suggest there are good things coming here. PURE continues to be one of the top traded stocks on the OTCBB. The stock looks great here as it continues to break out. PURE looks ripe for a continued run and deserves to be on investors watch lists here.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in PURE either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.